The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Effects of Age on the Detection and Management of Breast Cancer
Open accessAbstract
Currently, breast cancer affects approximately 12% of women worldwide. While the incidence of breast cancer rises with age, a younger age at diagnosis is linked to increased mortality. We discuss age related factors affecting breast cancer diagnosis, management and treatment, exploring key concepts and identifying critical areas requiring further research. We examine age as a factor in breast cancer diagnosis and treatment relating it to factors such as genetic status, breast cancer subtype, hormone factors and nodal status. We examine the effects of age as seen through the adoption of population wide breast cancer screening programs. Assessing the incidence rates of each breast cancer subtype, in the context of age, we examine the observed correlations. We explore how age affects patient’s prognosis, exploring the effects of age on stage and subtype incidence. Finally we discuss the future of breast cancer diagnosis and treatment, examining the potential of emerging tests and technologies (such as microRNA) and how novel research findings are being translated into clinically relevant practices.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J.-H., & Wolmark, N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa022152 · Cited by 6,249 · cited 1×
“The most common surgical intervention for breast cancer treatment is wide local excision (WLE), which has similar outcomes to mastectomy while reducing surgical complications [121,122].”
BackgroundA Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
Park, P. Y., Goldin, T., Chang, J., Markman, M., & Kundranda, M. N. (2015) · Case Reports in Oncology · doi:10.1159/000441772 · Cited by 5,273
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Veronesi, U., Cascinelli, N., Mariani, L., Greco, M., Saccozzi, R., Luini, A., Aguilar, M., & Marubini, E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020989 · Cited by 4,450
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,836
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Gianni, L., Pienkowski, T., Im, Y.-H., Roman, L., Tseng, L.-M., Liu, M.-C., Lluch, A., Staroslawska, E., de la Haba-Rodriguez, J., Im, S.-A., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70336-9 · Cited by 2,374
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,174
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
Carey, L. A., Dees, E. C., Sawyer, L., Gatti, L., Moore, D. T., Collichio, F., Ollila, D. W., Sartor, C. I., Graham, M. L., & Perou, C. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1109 · Cited by 2,087
Ma, J., & Jemal, A. (2013) · Breast Cancer Metastasis and Drug Resistance · doi:10.1007/978-1-4614-5647-6_1 · Cited by 1,907
Screening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802 · cited 1×
“BRCA1 and BRCA2 mutation carriers <70 years old face a 57% and 49% (respectively) risk of developing breast cancer [66].”
BackgroundKriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00008 · Cited by 1,686
Cuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M., & Forbes, J. F. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70257-6 · Cited by 1,674
A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052258 · Cited by 1,577
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Albain, K. S., Barlow, W. E., Shak, S., Hortobagyi, G. N., Livingston, R. B., Yeh, I.-T., Ravdin, P., Bugarini, R., Baehner, F. L., Davidson, N. E., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70314-6 · Cited by 1,407
Kuerer, H. M., Newman, L. A., Smith, T. L., Ames, F. C., Hunt, K. K., Dhingra, K., Theriault, R. L., Singh, G., Binkley, S. M., Sneige, N., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.460 · Cited by 1,330
Breast cancer statistics, 2011
DeSantis, C., Siegel, R., Bandi, P., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20134 · Cited by 1,326
Hughes, K. S., Schnaper, L. A., Bellon, J. R., Cirrincione, C. T., Berry, D. A., McCormick, B., Muss, H. B., Smith, B. L., Hudis, C. A., Winer, E. P., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2615 · Cited by 1,310
Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force
Nelson, H. D., Tyne, K., Naik, A., Bougatsos, C., Chan, B. K., & Humphrey, L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00009 · Cited by 1,248
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
Voduc, K. D., Cheang, M. C. U., Tyldesley, S., Gelmon, K., Nielsen, T. O., & Kennecke, H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9284 · Cited by 1,243
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
Nyström, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjöld, B., & Rutqvist, L. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08020-0 · Cited by 1,183
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171 · cited 1×
“Currently, bilateral prophylactic mastectomy has been shown to reduce the risk of breast cancer in carriers with BRCA1 and BRCA2 mutations [119].”
BackgroundBuzdar, A. U., Ibrahim, N. K., Francis, D., Booser, D. J., Thomas, E. S., Theriault, R. L., Pusztai, L., Green, M. C., Arun, B. K., Giordano, S. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.032 · Cited by 1,171
Carney, P. A., Miglioretti, D. L., Yankaskas, B. C., Kerlikowske, K., Rosenberg, R., Rutter, C. M., Geller, B. M., Abraham, L. A., Taplin, S. H., Dignan, M., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00008 · Cited by 1,142
Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force
Humphrey, L. L., Helfand, M., Chan, B. K. S., & Woolf, S. H. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_1-200209030-00012 · Cited by 1,137
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji250 · Cited by 1,118
Bartelink, H., Horiot, J.-C., Poortmans, P. M., Struikmans, H., Van den Bogaert, W., Fourquet, A., Jager, J. J., Hoogenraad, W. J., Oei, S. B., Wárlám-Rodenhuis, C. C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.4991 · Cited by 1,047
Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
Foulkes, W. D. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg050 · Cited by 970
BRCA1 and BRCA2: 1994 and beyond
Narod, S. A., & Foulkes, W. D. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1431 · Cited by 967 · cited 1×
“These genes are tumour suppressor genes responsible for DNA damage repair [63] and mutations in these genes result in a significantly increased risk of breast cancer.”
BackgroundAromatase Inhibitors in Breast Cancer
Smith, I. E., & Dowsett, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023246 · Cited by 905
Howell, A. (1998) · PubMed · Cited by 901
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., et al. (1996) · Nature Genetics · doi:10.1038/ng0396-333 · Cited by 839
Nguyen, P. L., Taghian, A. G., Katz, M. S., Niemierko, A., Abi Raad, R. F., Boon, W. L., Bellon, J. R., Wong, J. S., Smith, B. L., & Harris, J. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4287 · Cited by 811
Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
van der Groep, P., Bouter, A., van der Zanden, R., Menko, F. H., Buerger, H., Verheijen, R. H. M., van der Wall, E., & van Diest, P. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh114 · Cited by 798
Burstein, H. J., Temin, S., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., Rowden, D., Solky, A. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.2258 · Cited by 786
Diederichs, C., Berger, K., & Bartels, D. B. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq208 · Cited by 693
Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer
Diab, S. G. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.550 · Cited by 674
Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
Eroles, P., Bosch, A., Alejandro Pérez-Fidalgo, J., & Lluch, A. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.11.005 · Cited by 624
Inwald, E. C., Klinkhammer-Schalke, M., Hofstädter, F., Zeman, F., Koller, M., Gerstenhauer, M., & Ortmann, O. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2560-8 · Cited by 601
Gonzalez-Angulo, A. M., Timms, K. M., Liu, S., Chen, H., Litton, J. K., Potter, J., Lanchbury, J. S., Stemke-Hale, K., Hennessy, B. T., Arun, B. K., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2560 · Cited by 573
Cancer burden in the aged: an epidemiologic and demographic overview.
Yancik, R. (1997) · PubMed · Cited by 558
Ford, D., Easton, D. F., & Peto, J. (1995) · Europe PMC (PubMed Central) · Cited by 528
Effect of Screening Mammography on Breast-Cancer Mortality in Norway
Kalager, M., Zelen, M., Langmark, F., & Adami, H.-O. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000727 · Cited by 526
Genetics of breast cancer: a topic in evolution
Shiovitz, S., & Korde, L. A. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv022 · Cited by 525
Age as prognostic factor in premenopausal breast carcinoma
de la Rochefordière, A., Campana, F., Fenton, J., Vilcoq, J. R., Fourquet, A., Asselain, B., Scholl, S. M., Pouillart, P., Durand, J.-C., & Magdelenat, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)92407-k · Cited by 480
Cancer burden in the aged: An epidemiologic and demographic overview
Yancik, R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971001)80:7<1273::aid-cncr13>3.0.co;2-4 · Cited by 473
Veronesi, U., Salvadori, B., Luini, A., Greco, M., Saccozzi, R., del Vecchio, M., Mariani, L., Zurrida, S., & Rilke, F. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00271-j · Cited by 448
Under-Representation of Older Adults in Cancer Registration Trials: Known Problem, Little Progress
Scher, K. S., & Hurria, A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.6727 · Cited by 432
Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study
O'Brien, K. M., Cole, S. R., Tse, C.-K., Perou, C. M., Carey, L. A., Foulkes, W. D., Dressler, L. G., Geradts, J., & Millikan, R. C. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1533 · Cited by 429
Jochelson, M. S., Dershaw, D. D., Sung, J. S., Heerdt, A. S., Thornton, C., Moskowitz, C. S., Ferrara, J., & Morris, E. A. (2013) · Radiology · doi:10.1148/radiol.12121084 · Cited by 421
Hubbard, R. A., Kerlikowske, K., Flowers, C. I., Yankaskas, B. C., Zhu, W., & Miglioretti, D. L. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00004 · Cited by 414
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2747 · Cited by 409
U.S. Preventive Services Task Force* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-5-200509060-00011 · Cited by 405
Reproductive risk factors and breast cancer subtypes: a review of the literature
Anderson, K. N., Schwab, R. B., & Martinez, M. E. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2852-7 · Cited by 378
Regular self-examination or clinical examination for early detection of breast cancer
Kösters, J. P., & Gøtzsche, P. C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003373 · Cited by 372
Very young women (<35 years) with operable breast cancer: features of disease at presentation
Colleoni, M., Rotmensz, N., Robertson, C., Orlando, L., Viale, G., Renne, G., Luini, A., Veronesi, P., Intra, M., Orecchia, R., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf039 · Cited by 371
Rosenberg, R. D., Hunt, W. C., Williamson, M. R., Gilliland, F. D., Wiest, P. W., Kelsey, C. A., Key, C. R., & Linver, M. N. (1998) · Radiology · doi:10.1148/radiology.209.2.9807581 · Cited by 364
microRNA Expression Patterns Reveal Differential Expression of Target Genes with Age
Noren Hooten, N., Abdelmohsen, K., Gorospe, M., Ejiogu, N., Zonderman, A. B., & Evans, M. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010724 · Cited by 357 · cited 1×
“Recently age has been implicated as a factor affecting the differential expression of miRNAs [77–79].”
BackgroundCataliotti, L., Buzdar, A. U., Noguchi, S., Bines, J., Takatsuka, Y., Petrakova, K., Dube, P., & Tosello de Oliveira, C. (2006) · Cancer · doi:10.1002/cncr.21872 · Cited by 352
Nelson, H. D., Huffman, L. H., Fu, R., & Harris, E. L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-5-200509060-00012 · Cited by 346
Geisler, J., King, N., Dowsett, M., Ottestad, L., Lundgren, S., Walton, P., Kormeset, P., & Lønning, P. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.531 · Cited by 336
Hereditary breast cancer: new genetic developments, new therapeutic avenues
Campeau, P. M., Foulkes, W. D., & Tischkowitz, M. D. (2008) · Human Genetics · doi:10.1007/s00439-008-0529-1 · Cited by 320
How many more breast cancer predisposition genes are there?
Easton, D. F. (1999) · Breast Cancer Research · doi:10.1186/bcr6 · Cited by 315
Heneghan, H. M., Miller, N., Kelly, R., Newell, J., & Kerin, M. J. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-0103 · Cited by 315
Self-citationJakesz, R., Greil, R., Gnant, M., Schmid, M., Kwasny, W., Kubista, E., Mlineritsch, B., Tausch, C., Stierer, M., Hofbauer, F., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm246 · Cited by 312
Autier, P., Boniol, M., Gavin, A., & Vatten, L. J. (2011) · BMJ · doi:10.1136/bmj.d4411 · Cited by 300
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients
Calza, S., Hall, P., Auer, G., Bjöhle, J., Klaar, S., Kronenwett, U., Liu, E. T., Miller, L., Ploner, A., Smeds, J., et al. (2006) · Breast Cancer Research · doi:10.1186/bcr1517 · Cited by 262
Screening for breast cancer with mammography
Gøtzsche, P. C., & Nielsen, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub2 · Cited by 260
Young age: an independent risk factor for disease-free survival in women with operable breast cancer
Han, W., Kim, S. W., Ae Park, I., Kang, D., Kim, S.-W., Youn, Y.-K., Oh, S. K., Choe, K. J., & Noh, D.-Y. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-82 · Cited by 259 · cited 1×
“Prognosis of patients varies with age, as younger women tend to have more aggressive tumours (such as triple negative) and a higher recurrence rate [136–141].”
BackgroundHwang, E. S., Lichtensztajn, D. Y., Gomez, S. L., Fowble, B., & Clarke, C. A. (2013) · Cancer · doi:10.1002/cncr.27795 · Cited by 258
Jones, H. A., Antonini, N., Hart, A. A. M., Peterse, J. L., Horiot, J.-C., Collin, F., Poortmans, P. M., Oei, S. B., Collette, L., Struikmans, H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.5764 · Cited by 239
Stage 0 to stage III breast cancer in young women1
Gajdos, C., Tartter, P. I., Bleiweiss, I. J., Bodian, C., & Brower, S. T. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00257-x · Cited by 234
Simon, L. M., Edelstein, L. C., Nagalla, S., Woodley, A. B., Chen, E. S., Kong, X., Ma, L., Fortina, P., Kunapuli, S., Holinstat, M., et al. (2014) · Blood · doi:10.1182/blood-2013-12-544692 · Cited by 229
Leach, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66646-9 · Cited by 213
Effect of Tamoxifen on Lumbar Spine Bone Mineral Density in Postmenopausal Women After 5 Years
Love, R. R. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.22.2585 · Cited by 199
Theriault, R. L., Carlson, R. W., Allred, C., Anderson, B. O., Burstein, H. J., Edge, S. B., Farrar, W. B., Forero, A., Giordano, S. H., Goldstein, L. J., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0098 · Cited by 192
The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications
Honrado, E., Benítez, J., & Palacios, J. (2005) · Modern Pathology · doi:10.1038/modpathol.3800453 · Cited by 190
Tamoxifen and risk of idiopathic venous thromboembolism
Meier, C. R., & Jick, H. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00733.x · Cited by 184
Association between common risk factors and molecular subtypes in breast cancer patients
Turkoz, F. P., Solak, M., Petekkaya, I., Keskin, O., Kertmen, N., Sarici, F., Arik, Z., Babacan, T., Ozisik, Y., & Altundag, K. (2013) · The Breast · doi:10.1016/j.breast.2012.08.005 · Cited by 174
Bharat, A., Aft, R. L., Gao, F., & Margenthaler, J. A. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21268 · Cited by 174
Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups
Kurian, A. W., Fish, K., Shema, S. J., & Clarke, C. A. (2010) · Breast Cancer Research · doi:10.1186/bcr2780 · Cited by 171
Age-specific changes in intrinsic breast cancer subtypes: a focus on older women
Jenkins, E. O., Deal, A. M., Anders, C. K., Prat, A., Perou, C. M., Carey, L. A., & Muss, H. B. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0184 · Cited by 165
Nelson, H. D., Tyne, K., Naik, A. M., Bougatsos, C., Chan, B. K. S., Nygren, P., & Humphrey, L. L. (2009) · PubMed Central · doi:10.1059/0003-4819-151-10-200911170-00009 · Cited by 164
Kerlikowske, K. M. (1996) · JAMA · doi:10.1001/jama.276.1.39 · Cited by 164
Analysis of local and regional recurrences in breast cancer after conservative surgery
Botteri, E., Bagnardi, V., Rotmensz, N., Gentilini, O., Disalvatore, D., Bazolli, B., Luini, A., & Veronesi, U. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp386 · Cited by 161
The Korean Breast Cancer Society, Han, W., & Kang, S. Y. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0388-z · Cited by 159
Hamaker, M. E., Seynaeve, C., Wymenga, A. N. M., van Tinteren, H., Nortier, J. W. R., Maartense, E., de Graaf, H., de Jongh, F. E., Braun, J. J., Los, M., et al. (2013) · The Breast · doi:10.1016/j.breast.2013.11.004 · Cited by 148
Kroman, N. T., Holtveg, H., Wohlfahrt, J., Jensen, M., Mouridsen, H. T., Blichert-Toft, M., & Melbye, M. (2004) · Cancer · doi:10.1002/cncr.20022 · Cited by 146
microRNAs in breast cancer development and treatment
Serpico, D., Molino, L., & Cosimo, S. D. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.002 · Cited by 138
Regulation of Stem Cell Populations by microRNAs
Mathieu, J., & Ruohola‐Baker, H. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6621-1_18 · Cited by 130
Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer
McDermott, A. M., Miller, N., Wall, D., Martyn, L. M., Ball, G., Sweeney, K., & Kerin, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087032 · Cited by 125
Self-citationLei, J., Yang, P., Zhang, L., Wang, Y., & Yang, K. (2013) · European Radiology · doi:10.1007/s00330-013-3012-x · Cited by 112
Epigenetic Control of MicroRNA Expression and Aging
Liang, R., Bates, D., & Wang, E. (2009) · Current Genomics · doi:10.2174/138920209788185225 · Cited by 111
Partridge, A. H., Gelber, S. I., Piccart, M. J., Focant, F., Scullion, M. J., Holmes, E. M., Winer, E. P., & Gelber, R. D. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.1956 · Cited by 110
Likelihood Ratios for Modern Screening Mammography
Kerlikowske, K. M. (1996) · JAMA · doi:10.1001/jama.1996.03540010041028 · Cited by 109
Comorbidity and survival after early breast cancer. A review
Land, L. H., Dalton, S. O., Jørgensen, T. L., & Ewertz, M. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.03.001 · Cited by 108
Webb, M. L., Cady, B., Michaelson, J. S., Bush, D. M., Calvillo, K. Z., Kopans, D. B., & Smith, B. L. (2013) · Cancer · doi:10.1002/cncr.28199 · Cited by 108
Le‐Petross, H. T., Whitman, G. J., Atchley, D. P., Yuan, Y., Gutierrez‐Barrera, A. M., Hortobágyi, G. N., Litton, J. K., & Arun, B. (2011) · Cancer · doi:10.1002/cncr.25971 · Cited by 105
Epidemiology of Breast Cancer in Young Women
Yankaskas, B. C. (2006) · Breast Disease · doi:10.3233/bd-2006-23102 · Cited by 104
TNT Trial TMG, B. (., Robertson, L. B., Hanson, H., Seal, S., Warren-Perry, M., Hughes, D., Howell, I., Turnbull, C., Houlston, R. S., Shanley, S., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.31 · Cited by 97
Colleoni, M. A., Rotmensz, N., Peruzzotti, G., Maisonneuve, P., Orlando, L., Ghisini, R., Viale, G., Pruneri, G., Veronesi, P., Luini, A., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl145 · Cited by 89
Risk reducing mastectomy: outcomes in 10 European centres
Evans, D. G., Baildam, A. D., Anderson, E. D. C., Brain, A., Shenton, A., Vasen, H. F. A., Eccles, D., Lucassen, A., Pichert, G., Hamed, H., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062232 · Cited by 87
Webb, M. L., Kopans, D. B., & Cady, B. (2013) · Cancer · doi:10.1002/cncr.28525 · Cited by 82
Albert, J. M., Gonzalez-Angulo, A. M., Güray, M., Şahin, A. A., Strom, E. A., Tereffe, W., Woodward, W. A., Tucker, S. L., Hunt, K. K., Hortobágyi, G. N., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.011 · Cited by 82
Barthélémy, P., Heitz, D., Mathelin, C., Polesi, H., Asmane, I., Litique, V., Rob, L., Bergerat, J., & Kurtz, J. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.06.005 · Cited by 80
Aaldriks, A. A., Giltay, E. J., le Cessie, S., van der Geest, L. G., Portielje, J. E. A., Tanis, B. C., Nortier, J. W. R., & Maartense, E. (2013) · The Breast · doi:10.1016/j.breast.2013.01.011 · Cited by 80
Land, L. H., Dalton, S. O., Mb, J., & Ewertz, M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.472 · Cited by 76
Hatse, S., Brouwers, B. A. H., Dalmasso, B., Laenen, A., Kenis, C., Schöffski, P., & Wildiers, H. P. M. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110644 · Cited by 73
Warner, E. T., Colditz, G. A., Palmer, J. R., Partridge, A. H., Rosner, B. A., & Tamimi, R. M. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2721-9 · Cited by 73
Dai, X., Chen, A., & Bai, Z. (2014) · Scientific Reports · doi:10.1038/srep06566 · Cited by 73
Mahmood, U. X., Morris, C. G., Neuner, G. A., Koshy, M., Kesmodel, S. B., Buras, R., Chumsri, S., Bao, T., Tkaczuk, K. H. R., & Feigenberg, S. J. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.10.075 · Cited by 72
Saadatmand, S., Tilanus‐Linthorst, M. M. A., Rutgers, E. J. T., Hoogerbrugge, N., Oosterwijk, J. C., Tollenaar, R. A. �. �., Hooning, M. J., Loo, C. E., Obdeijn, I.-M., Heijnsdijk, E. A. M., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt203 · Cited by 65
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
Christodoulatos, G. S., & Dalamaga, M. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i2.71 · Cited by 60
Automated Whole-Breast Ultrasound: Advancing the Performance of Breast Cancer Screening
Kelly, K. M., & Richwald, G. A. (2011) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2011.02.004 · Cited by 56
The risk of breast cancer in women with a BRCA1 mutation from North America and Poland
Lubiński, J., Huzarski, T., Byrski, T., Lynch, H. T., Cybulski, C., Ghadirian, P., Stawicka, M., Foulkes, W. D., Kilar, E., Kim‐Sing, C., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26369 · Cited by 46
Gene-expression assays: New tools to individualize treatment of early-stage breast cancer
Dobbe, E., Gurney, K., Kiekow, S., Lafferty, J. S., & Kolesar, J. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060352 · Cited by 34
Breast cancer screening halves the risk of breast cancer death: A case-referent study
Paap, E., Verbeek, A. L. M., Botterweck, A. A. M., van Doorne-Nagtegaal, H. J., Tas, M. W., de Koning, H. J., Otto, S. J., de Munck, L., van der Steen, A., Holland, R., et al. (2014) · The Breast · doi:10.1016/j.breast.2014.03.002 · Cited by 33
Kim, H. J., Han, W., Yi, O. V., Shin, H.-C., Ahn, S., Koh, B. S., Moon, H., You, J. H., Son, B. H., Ahn, S. H., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1736-3 · Cited by 33
Age at diagnosis in women with non-metastatic breast cancer: Is it related to prognosis?
Alieldin, N., Abo-Elazm, O. M., Bilal, D., Salem, S., Gouda, E., El-Mongy, M., & Ibrahim, A. S. (2013) · Journal of the Egyptian National Cancer Institute · doi:10.1016/j.jnci.2013.08.005 · Cited by 29
Immunohistochemical Biomarkers in Patients with Early-Onset Breast Carcinoma by Tissue Microarray
Choi, D. H., Kim, S., Rimm, D. L., Carter, D., & Haffty, B. G. (2005) · The Cancer Journal · doi:10.1097/00130404-200509000-00008 · Cited by 28
A Prospective Study of the Use and Effects of Screening Mammography in Women Aged 70 and Older
Vacek, P. M., & Skelly, J. M. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13184 · Cited by 27
Grassadonia, A., Nicola, M. D., Grossi, S., Noccioli, P., Tavoletta, S., Politi, R., Angelucci, D., Marinelli, C., Zilli, M., Cèfaro, G. A., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3535-7 · Cited by 14
Kim, K., Chie, E. K., Han, W., Noh, D., Oh, D., Im, S., Kim, T., Bang, Y., & Ha, S. W. (2010) · The Breast Journal · doi:10.1111/j.1524-4741.2010.01021.x · Cited by 10
Cited by
Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021) · Cancers · doi:10.3390/cancers13174287 · Cited by 1,960
Almansour, N. M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.836417 · Cited by 397
Bani Mohammad, E., & Ahmad, M. (2019) · Palliative and Supportive Care · doi:10.1017/s1478951518000639 · Cited by 264
Metadata
- Authors
- McGuire, A., Brown, J., Malone, C., McLaughlin, R., & Kerin, M.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2015-05-22
- Volume
- 7
- Issue
- 2
- Pages
- 908-929
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W1737947457
- Cited by
- 374
- References
- 152
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.